GlassScriptPhysician profile
Jody A Adams
NPI 1275500522
$2,172.61
in general payments reported to CMS, 2019-2025
42 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $368 · 2023: $599 · 2024: $124 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485 · Education: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.23 |
| Education | $318.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $237.57 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Seagen INC. | $140.08 | 2022-2023 | Tukysa |
| Novartis Pharmaceuticals Corporation | $118.30 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $115.35 | 2023-2025 | Enhertu, Calquence, Lynparza |
| Genzyme Corporation | $112.16 | 2022-2025 | |
| Sobi, INC | $111.91 | 2022-2023 | |
| Lilly USA, LLC | $99.84 | 2025 | Jaypirca |
| Sanofi-Aventis U.S. LLC | $99.00 | 2024 | |
| Abbvie INC. | $63.05 | 2024-2025 | |
| Janssen Biotech, INC. | $61.08 | 2022-2025 | Rybrevant |
| Sumitomo Pharma America, INC. | $53.78 | 2023-2025 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $52.12 | 2022-2025 | Opdivo |
| Adc Therapeutics America, INC. | $50.77 | 2023-2025 | |
| Beigene USA, INC. | $49.98 | 2023 | Brukinsa |
| Amneal Pharmaceuticals LLC | $48.34 | 2023-2025 | Alymsys, Neupogen, Avastin |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.